Tumor necrosis factor a: a matter of life and death Tumor necrosis factor a (TNF-a) is a proinflammatory cytokine implicated in a variety of peripheral inflammatory human diseases including rheumatoid arthritis, asthma, ankylosing spondylitis, cancer and neurodegenerative disorders such as Alzheimer's disease (AD). TNF-a is generated as a membrane-bound polypeptide precursor that is processed by proteolysis. TNF-a synthesis and secretion are controlled by TNF-a converting enzyme (T-ACE). The secreted form then homotrimerizes to form the active TNF-a ligand. TNF-a binds with high affinity to two types of transmembrane-spanning receptors, TNFR1 and TNFR2, to exert most of its actions (Figure 1 ). These receptors belong to the larger TNFR superfamily [1] . Although TNFR1 is more ubiquitous, both TNFR1 and TNFR2 are present on virtually all cell types, except, most notably, red blood cells. Indicative of its name, TNF-a has long been associated with induction of apoptotic cell death. However, considerable evidence now exists that TNF-a also exerts converse actions such as cellular proliferation, differentiation and neuroprotection.
Considerable evidence has demonstrated that TNF-a acts as a potent neuroinflammatory agent within the central nervous system (CNS) and has been linked to disorders such as AD and Parkinson's disease (PD). However, as with other cytokines within the CNS, pleiotropic activities are often seen, that is, TNF-a mediates neuroprotective actions as well as the more typically observed apoptotic actions [2] [3] [4] . Exactly how the same molecule can exert these converse effects and how this diversity is exploited physiologically is presently unclear. This crucial topic is the major discussion point of this article. Recent advances in our appreciation of how transmembrane receptor systems can be compartmentalized within discrete signaling microdomains might shed light upon the potential mechanisms by which TNF-a's protean nature is generated. One hypothetical model which could account for such controlled signaling diversity is the generation of multiple stable receptor states in specific microdomains that show a predilection to generate discrete signaling outputs. We will describe evidence demonstrating the functional flexibility of TNF-a and how different TNF-a receptor states could explain its pleiotropic activity within the CNS.
TNF-a activity in the brain: two sides of one coin
In this section we describe how a single ligand, TNF-a, can act in different regions of the brain in multiple ways to control a diverse array of physiological processes; an indepth understanding of the underlying signaling mechanisms might facilitate our ability to selectively control discrete aspects of TNF-a function. The production and secretion of inflammatory cytokines are processes associated with both neuronal and peripheral immunity. The CNS possesses its own immune system which includes microglia. When activated, microglia secrete multiple factors that can ensure neuronal survival, but are also able to initiate apoptosis of fatally damaged neurons through the secretion and production of inflammatory precursors such as TNF-a [5] . It has been demonstrated that overstimulation of microglia, through amyloid b-peptide (Ab) deposits [6] or as a result of severe head trauma, causes an excessive secretion of TNF-a, which leads to neuronal cell apoptosis. Severe inflammation within the CNS can prove fatal for neurons and can be induced by severe head trauma in various neurological disorders including PD, multiple sclerosis (MS), AD and amyotrophic lateral sclerosis [7] . By illuminating several examples, we will demonstrate that in most physiological scenarios, however, TNF-a readily demonstrates a protean signaling nature, namely both classically apoptotic or the more recent neuroprotective capacity.
TNF-a and neurotoxicity
Although initially designated as a cytotoxic agent, TNF-a has been shown to have clear protective activity with respect to neurotoxic insults [8, 9] . There are many mechanisms by which TNF-a can exert a neuroprotective action, including stimulation of neuronal plasticity; NF-kB activation; induction of antiapoptotic factors; intracellular calcium buffering; and stimulation of neurotrophic factor release from astroglia [10] [11] [12] [13] . With regard to disorders such as AD, TNF-a exerts a particularly strong neuroprotective action against hippocampal insults such as NMDA Opinion
